Información*
| Nombre | GILDARDO RIVERA SANCHEZ |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS DE LA VIDA |
| Disciplina | QUÍMICA FARMACÉUTICA |
| Especialidad | FARMACEUTICA |
| CVU | 111516 |
| Institución | |
|---|---|
| Dependencia | UNIDADES ACADEMICAS DE INVESTIGACION CIENTIFICA Y TECNOLOGICA |
| Entidad | TAMAULIPAS |
| Nivel | 3 |
| Vigencia | Inicio: 01/01/2023 |
| Fin: 31/12/2027 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Últimas publicaciones Scopus
- 2026
- Biological evaluation of guanidines, bisguanidines, and their derivatives as anti-Trypanosoma cruzi agents Bioorganic and Medicinal Chemistry Letters · Vol. 138 Article
- Antitrypanosomatid and antiamitochondriate activity of new cyclohexyl-quinoxaline-7-carboxylate-1,4-di-N-oxide derivatives: An in silico and in vitro approach toward the elucidation of their mechanisms of action Biomedicine and Pharmacotherapy · Vol. 202 Article
- Chemical synthesis and biological activity of semisynthetic derivatives against Chagas disease and leishmaniasis composed of fragments of natural products and 1,2,3-triazine 1-oxide scaffold Biomedicine and Pharmacotherapy · Vol. 202 Article
- Purine derivatives as potential agents against Chagas disease: Ex vivo, in vitro, in silico evaluation, and identification of targets in Trypanosoma cruzi Biomedicine and Pharmacotherapy · Vol. 200 Article
- Discovery of 4-carboxylate-1,2,3-triazine 1-oxide, their 1,2,3-triazine, and the 3,6-dihydro analogs, as new agents against Chagas diseases and Leishmaniasis Biomedicine and Pharmacotherapy · Vol. 199 Article